July 25, 2013
Ipswich, MA – NEBsolutions, a dedicated team of customized reagent and service specialists at New England Biolabs® (NEB), is pleased to offer a suite of reagents and capabilities for molecular diagnostics (MDx) product development, at this year’s Annual Meeting of the American Association of Clinical Chemistry (AACC). NEB, a leader in the development and production [...]
Dotmatics Cloud Hosted Platform Enables AstraZeneca Neuroscience Drug Discovery Collaborations
July 25, 2013
Bishops Stortford, UK. Dotmatics announced today that the AstraZeneca Neuroscience Innovative Medicines Unit (iMed) has selected its Cloud based informatics platform as their research data management solution. The Dotmatics platform provides a single point of access to all data and functions across multidisciplinary groups. The platform includes compound registration and tracking, biological screening, DMPK analysis, [...]
July 25, 2013
PARIS, - Mauna Kea Technologies (NYSE Euronext: MKEA, FR0010609263), leader in the optical biopsy market and developer of Cellvizio®, the fastest way to see cancer, has entered several distribution agreements for its line of Cellvizio LAB products, including the Cellvizio Dual Band, for preclinical research. With new partnerships in place in North America, Taiwan, Italy, [...]
July 25, 2013
BASINGSTOKE, United Kingdom -- Food microbiology laboratories can now confidently test to a recognized standard forListeria monocytogenes with the Thermo Scientific SureTect Listeria monocytogenes Assay, which has been granted Performance Tested MethodSM status by the AOAC Research Institute. Listeria monocytogenes can be present in a variety of foodstuffs, including some processed meats and cheeses, and [...]
Marks Company’s 17th Patent Issued
July 25, 2013
WILMINGTON, MA -- Implant Sciences Corporation (OTCQB: IMSC), a high technology supplier of systems and sensors for homeland security and defense markets, today announced the United States Patent and Trademark Office has issued the Company patent #8,469,295, titled "Trace Chemical Particle Release Nozzle." This patent relates to a method of leveraging air jets and/or aerosols [...]
Eurofins Panlabs strengthens drug discovery services with GE Healthcare’s Cytiva™ Cardiomyocytes
July 25, 2013
Eurofins Scientific (EUFI.PA), the world leader in food, environment and pharmaceutical products testing, has signed an agreement with GE Healthcare for the exclusive right to offer GE Healthcare’s Cytiva™ Cardiomyocytes for drug discovery and early development cardio toxicity screening services. The agreement allows Eurofins Panlabs to provide a unique offering for an early predictive measure [...]
Trovagene Announces Issuance of Broad MicroRNA Patent
July 24, 2013
SAN DIEGO, -- Trovagene, Inc. (NASDAQ: TROV), a developer of cell-free molecular diagnostics, announced the issuance of US patent 8,486,626, "Methods of detecting cell-free miRNA in urine and blood." The patent pertains to the detection and quantitation of microRNA (miRNA) using a wide variety of technologies and platforms. MicroRNAs are known to play critical roles [...]
3D Biomatrix Files Patent for Hanging Drop Transfer Plate Technology
July 24, 2013
Ann Arbor, MI - 3D Biomatrix, a leader in three-dimensional (3D) cell culture products, is pleased to announce that it has filed a patent for its technology for transferring spheroids from the company’s 96-well or 384-well Perfecta3D Hanging Drop Plates to a receiving plate for analysis of the spheroids. The transfer plate designed for the [...]
LifeSpan BioSciences Expands IHC-plusTM Product Line To More Than 10,000 Antibodies
July 24, 2013
SEATTLE, WA, -- LifeSpan BioSciences, Inc.(LSBio), a leading provider of antibodies for researchers worldwide, has increased the number of validated IHC-plusTM antibodiesavailable in its catalog to more than 10,000. With this increase, LSBiois well on its way to its goal of building the world's largest catalog of 20,000 well characterized, IHC-validated reagent antibodies. Overall, LSBiohas [...]
July 24, 2013
LGC is pleased to announce the release of a new automated nucleic acid extraction platform - oKtopureTM – which will drive significant increases in throughput and productivity while enabling reductions in consumable costs of up to 50%. The new oKtopureTM DNA extraction platform combines higher throughput with high quality DNA extractions and is capable of [...]
